Robert Befidi, President, Diagnostics at Envista Holdings Corp.. Biography, career history and compensation sourced from Envista Holdings Corp. SEC filings and official company website.
About
Envista's site describes Robert Befidi as President, Diagnostics, overseeing intraoral scanning, imaging and DTX businesses. He previously served at 3M as President of the Separation and Purification Sciences Division and led the go-to-market transformation for the Medical Solutions Division; earlier he worked in private equity, consulting and investment banking research at Piper Sandler and co-founded Gordian Capital. He holds an MBA from the Wharton School, an M.S. in Software Engineering from the University of Minnesota, and a B.S. in Computer Science from Winona State University.
Roles
Envista Holdings Corp.
President, Diagnostics · Current role
2023–present
3M Company
President, Separation and Purification Sciences Division
—
Gordian Capital
Co-Founder
—
Piper Sandler Companies
Investment banking research
—
Fixed Compensation
FY 2025
Salary
$567,308
ComponentAnnual base salary
All other compensation
$47,847
Total compensation
$1,936,267
Performance Compensation
Data from FY 2025
Cash incentive
Non-equity incentive plan compensation
$470,925
FormCash
Target Opportunity
—
PlanExecutive Incentive Compensation Plan (ICP)
Evaluation periodFY2025
Stock awards
Stock awards
$637,674
FormRSUs and PSUs under the 2019 Omnibus Incentive Plan
ValuationGrant date fair value (ASC 718)
Option awards
$212,513
FormStock options under the 2019 Omnibus Incentive Plan